Records 1 - 30 (of 39 Records)
|Query Trace: Tuberculosis and GSTM1[original query]|
| Genetic polymorphisms of cytochrome P450 and glutathione S-transferase associated with antituberculosis drug-induced hepatotoxicity in Chinese tuberculosis patients.
The Journal of international medical research 0 38 (3): 977-86.
Wang T, Yu H T, Wang W, Pan Y Y, He L X, Wang Z
| GSTT1 and GSTM1 gene deletions are not associated with hepatotoxicity caused by antitubercular drugs.
Journal of clinical pharmacy and therapeutics 2010 Aug 35 (4): 465-70.
Chatterjee S, Lyle N, Mandal A, Kundu
| Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients.
Memórias do Instituto Oswaldo Cruz 2011 Sep 106 (6): 716-24.
Teixeira Raquel Lima de Figueiredo, Morato Renata Gomes, Cabello Pedro Hernan, Muniz Ligia Mayumi Kitada, Moreira Adriana da Silva Rezende, Kritski Afrânio Lineu, Mello Fernanda Carvalho Queiroz, Suffys Philip Noel, Miranda Antonio Basilio de, Santos Adalberto Rezen
| The roles of GSTM1 and GSTT1 null genotypes and other predictors in anti-tuberculosis drug-induced liver injury.
Journal of clinical pharmacy and therapeutics 2012 Jul .
Monteiro TP, El-Jaick KB, Jeovanio-Silva AL, Brasil PE, Costa MJ, Rolla VC, de Castro L
| Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.
Molecular diagnosis & therapy 2012 Jul .
Costa GN, Magno LA, Santana CV, Konstantinovas C, Saito ST, Machado M, Di Pietro G, Bastos-Rodrigues L, Miranda DM, De Marco LA, Romano-Silva MA, Rios-Santos F
| CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study.
Journal of clinical pharmacy and therapeutics 2012 Oct 37 (5): 588-93.
Tang S-W, Lv X-Z, Zhang Y, Wu S-S, Yang Z-R, Xia Y-Y, Tu D-H, Deng P-Y, Ma Y, Chen D-F, Zhan S
| GSTM1 and GSTT1 null polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2013 Jan 17 (1): 17-25.
Tang N, Deng R, Wang Y, Lin M, Li H, Qiu Y, Hong M, Zhou
| Relationship of NAT2, CYP2E1 and GSTM1/GSTT1 polymorphisms with mild elevation of liver enzymes in Brazilian individuals under anti-tuberculosis drug therapy.
Clinica chimica acta; international journal of clinical chemistry 2013 Jan 415 215-9.
Forestiero Francisco Jose, Cecon Leticia, Hirata Mario Hirouki, de Melo Fernando Fiuza, Cardoso Rosilene Fressatti, Cerda Alvaro, Hirata Rosario Dominguez Cres
| GSTM1 and GSTT1 genetic polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity: an updated meta-analysis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2013 Feb .
Li C, Long J, Hu X, Zhou Y
| N-acetyltransferase 2, cytochrome P4502E1 and glutathione S-transferase genotypes in antitubercular treatment-induced hepatotoxicity in North Indians.
Journal of clinical pharmacy and therapeutics 2014 Feb 39 (1): 91-6.
Rana S V, Sharma S K, Ola R P, Kamboj J K, Malik A, Morya R K, Sinha S
| Genetic polymorphisms of CYP2E1 and GSTM1 loci and susceptibility to anti-tuberculosis drug-induced hepatotoxicity.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2014 May 18 (5): 588-93.
Sharma S K, Jha B K, Sharma A, Sreenivas V, Upadhyay V, Jaisinghani C, Singla R, Mishra H K, Soneja
| Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity.
Tuberculosis (Edinburgh, Scotland) 2014 May 94 (3): 293-8.
Singla Neha, Gupta Dheeraj, Birbian Niti, Singh Jagt
| Impact of glutathione S-transferase M1 and T1 on anti-tuberculosis drug-induced hepatotoxicity in Chinese pediatric patients.
PloS one 2014 9 (12): e115410.
Liu Fang, Jiao An-xia, Wu Xi-rong, Zhao Wei, Yin Qing-qin, Qi Hui, Jiao Wei-wei, Xiao Jing, Sun Lin, Shen Chen, Tian Jian-ling, Shen Dan, Jacqz-Aigrain Evelyne, Shen A-do
| Genetic polymorphisms in metabolic enzymes and susceptibility to anti-tuberculosis drug-induced hepatic injury.
Genetics and molecular research : GMR 2014 13 (4): 9463-71.
Feng F M, Guo M, Chen Y, Li S M, Zhang P, Sun S F, Zhang G
| The incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1.
PloS one 2014 9 (1): e85905.
Xiang Yang, Ma Long, Wu Weidong, Liu Wei, Li Yongguang, Zhu Xia, Wang Qian, Ma Jinfeng, Cao Mingqin, Wang Qian, Yao Xuemei, Yang Lei, Wubuli Atikaimu, Merle Corinne, Milligan Paul, Mao Ying, Gu Jiayi, Xin Xium
| Meta-Analysis-Based Preliminary Exploration of the Connection between ATDILI and Schizophrenia by GSTM1/T1 Gene Polymorphisms.
PloS one 2015 10 (6): e0128643.
Cai Lei, Cai Mei-Hong, Wang Mei-Yan, Xu Yi-Feng, Chen Wen-Zhong, Qin Shen-Ying, Wan Chun-Ling, He L
| Genotype and allele frequencies of isoniazid-metabolizing enzymes NAT2 and GSTM1 in Latvian tuberculosis patients.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2016 Jul 22 (7): 472-7.
Igumnova Viktorija, Capligina Valentina, Krams Alvils, Cirule Andra, Elferts Didzis, Pole Ilva, Jansone Inta, Bandere Dace, Ranka Rena
| Factors associated with anti-TB drug-induced hepatotoxicity and genetic polymorphisms in indigenous and non-indigenous populations in Brazil.
Tuberculosis (Edinburgh, Scotland) 2016 Dec 101 15-24.
Heinrich Melissa M, Zembrzuski Verônica M, Ota Marcos M, Sacchi Flavia P, Teixeira Raquel L F, Cabello Acero Pedro H, Cunha Geraldo Marcelo, Souza-Santos Reinaldo, Croda Julio, Basta Paulo
| Polymorphisms of NAT2, CYP2E1, GST, and HLA related to drug-induced liver injury in indonesian tuberculosis patients.
International journal of mycobacteriology 0 7 (4): 380-386.
Perwitasari Dyah Aryani, Darmawan Endang, Mulyani Ully Adhi, Vlies Pieter Van Der, Alffenaar Jan-Willem C, Atthobar Jarir, Wilffert B
| The association between BACH1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2018 12 66 217-221.
Zhang Haiping, Qian Haisheng, Tao Bilin, Yang Miaomiao, Gong Jingye, Yi Honggang, Tang Shaow
| Are genetic variations in glutathione S-transferases involved in anti-tuberculosis drug-induced liver injury? A meta-analysis.
Journal of clinical pharmacy and therapeutics 2019 Aug .
Zhang Meng, Wu Shou-Quan, He Jian-Qi
| Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis.
BMJ open 2019 Aug 9 (8): e027940.
Yang Seungwon, Hwang Se Jung, Park Jung Yun, Chung Eun Kyoung, Lee Jangik
| Clinical and Molecular Risk Factors of Anti-tubercular Therapy Induced Hepatitis.
Journal of clinical and experimental hepatology 2019 4 9 (2): 200-206.
Kar Premashis, Karna Rahul, Ruttala Rajesh, Arora Shilpa, Chakravarty Anita, Kumar Sure
| Relationship of anti-tuberculosis drug-induced liver injury and genetic polymorphisms in CYP2E1 and GST.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2019 Nov .
Santos Eliana Abreu, Gonçalves José Carlos Saraiva, Fleury Marcos K, Kritski Afrânio L, Oliveira Martha M, Velasque Luciane S, E Silva José Roberto Lapa, Estrela Rita de Cássia
| [FREQUENCY OF POLYMORPHIC VARIANTS OF GSTT1 AND GSTM1 GENES IN PATIENTS WITH PULMONARY TUBERCULOSIS IN GEORGIAN POPULATION].
Georgian medical news 2019 Nov (296): 111-116.
Jokhadze T, Buadze T, Gaiozishvili M, Kiria N, Khujadze I, Lezhava
| CYP2E1, GSTM1, and GSTT1 genetic polymorphisms and their associations with susceptibility to antituberculosis drug-induced liver injury in Thai tuberculosis patients.
Heliyon 2021 5 7 (4): e06852.
Chanhom Noppadol, Wattanapokayakit Sukanya, Satproedprai Nusara, Suvichapanich Supharat, Mahasirimongkol Surakameth, Chaikledkaew Usa, Udomsinprasert Wanvisa, Mushiroda Taisei, Jittikoon Jiraph
| Glutathione-S-transferase genetic polymorphism and risk of hepatotoxicity to antitubercular drugs in a North-African population: A case-control study.
Gene 2021 10 809 146019.
Chbili Chahra, Fathallah Neila, Laadhari Chayma, Ouni Bouraoui, Saguem Saad, Ben Fredj Maha, Abdelghani Ahmed, Ben Saad Helmi, Ben Salem Chak
| Relevance of gene polymorphisms of NAT2 and NR1I2 to anti-tuberculosis drug-induced hepatotoxicity.
Xenobiotica; the fate of foreign compounds in biological systems 2022 6 52 (5): 520-526.
Wang Ning, Guo Shaochen, Liu Haiting, Ding Yangming, Yao Rong, Liu Zhongquan, Zhu Hui, Chen Xi, Yang Xinting, Chen Xiaoyou, Lu
| GSTT1/GSTM1 Genotype and Anti-Tuberculosis Drug-Induced Hepatotoxicity in Peruvian Patients.
International journal of molecular sciences 2022 10 23 (19): .
Jaramillo-Valverde Luis, Levano Kelly S, Tarazona David D, Vasquez-Dominguez Andres, Toledo-Nauto Anel, Capristano Silvia, Sanchez Cesar, Tarazona-Santos Eduardo, Ugarte-Gil Cesar, Guio Heinn
| Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort.
medRxiv : the preprint server for health sciences 2023 9 .
Gustavo Amorim, James Jaworski, Marcelo Cordeiro-Santos, Afrânio L Kritski, Marina C Figueiredo, Megan Turner, Bruno B Andrade, Digna R Velez Edwards, Adalberto R Santos, Valeria C Rolla, Timothy R Sterling, David W Haas,